ISHARES BIOTECHNOLOGY ETF (IBB) - Price, trends, fundamentals and chart - Passport to Wall Street

ISHARES BIOTECHNOLOGY ETF (NASDAQ: IBB)

Overview

current price

$129.16

$129.16

change

1.93 | 1.52%

1.93 | 1.52%

Yesterday's Close

127.23

open

127.62

volume

0.89 M

30d. avg volume.

1.65 M

1 day

127.58 - 129.34

52 weeks

104.29 - 138.74

p/e

0.00

beta

0.8340

market cap

8.11 B

dividend yield

0.27%

Industry

-

News and Commentary

FDA Approves Alzheimer's Drug Slowing Cognitive Decline The Food and Drug Administration (FDA) announced accelerated approval for lecanemab which showed evidence that it was able to slow cognitive decline in people with mild impairmen...

Here’s Why Investors Should Consider Biotech, Pharmaceutical Stocks The financial markets are not the most pleasant and calm place right now. It's facing risks in multiple areas such as geopolitics, inflation, and economic growth. There's also th...

Biotech ETFs May Need to Prepare for More Losses Ahead Biotechnology stocks faced their worst April on record, and more pain may be ahead for biotech-focused exchange traded funds (ETF).Popular biotech-focus...

Biotechs Setting up for a Strong 2021 From 2009 to the middle of 2015, biotechs were one of the strongest sectors in the market. Over this period, the iShares Nasdaq Biotechnology ETF

Moderna Vaccine Update May Boost Biotech ETFs Moderna (MRNA

Biotechs Break Out to New Highs For the past couple of years, the biotech sector (

Biotechs Setting Up, Fundamentals Improving The biotech sector is exhibiting remarkable strength and resilience during these turbulent market conditions. Interestingly, biotechs were actually a laggard during the last leg...

Gene Editing Stocks Could Power Next Leg of Biotech Bull Market Since this current bull market began in March 2009, one of the leading sectors has been biotech stocks

ETF Weekly: Industry Leaders Discuss 2020 Trends at Inside ETFs As exchange-traded fund industry leaders are meeting for the Inside ETFs, the world's largest ETF conference, this week, let's take a look at the latest trends that will be discu...

The only way Ill play biotech… The biotech sector has a reputation for making traders millions in a split second, but for most of the thousands of traders I have met and taught over the years they seem to be o...

StockTwits

Join now and unlock premium features

Access to premium stock and ETF data including financials, holdings and more
Participate in trading contests and earn real prizes
Sync you favorite articles and symbols between all of your device
And much more